Worth the Wait - Supporting Young Adult Cancer Survivors on the Path to Parenthood: Mike Scherer by i3 Health

Optimizing Sacituzumab Govitecan Tolerability in TNBC With Early Management: Antonio Llombart, MD by i3 Health

Understanding Lung Cancer Diagnostic Trends to Inform Therapeutic Development: Jess Paulus, SCd by i3 Health

Intuitively Designing Clinical Trials to Empower Patients: Ishwaria Subbiah, MD by i3 Health

Updated Results from the SPOTLIGHT and EV-302 Trials at ASCO: Ahsan Arozullah, MD, MPH by i3 Health

At the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Oncology Data Advisor sat down with Erica Fortune, PhD, Vice President of Research at Cancer Support Community, to discuss her team’s poster entitled, “Head and Neck Cancer (HNC) Survivors: Long-Term Nutrition Impact Symptoms, Eating Problems, and Barriers to Care Impact Psychosocial Health.”

In this podcast, Dr. Fortune delves further into this topic, including:

Background about long-term side effects and quality-of-life impacts experienced by HNC survivors

Cancer Support Community’s survey designed to further investigate these challenges

The results that the study found regarding nutrition, eating problems, and barriers to care that survivors experience

How Cancer Support Community plans on using the survey results to improve survivorship and address psychosocial impacts experienced by long-term HNC survivors

A preview of other topics that Cancer Support Community is excited to cover as a member organization of the Oncology Data Advisor Editorial Board

And more!

At the conclusion of this year’s American Society of Clinical Oncology (ASCO) Annual Meeting, Monzr Al Malki, MD, an Associate Professor in the Department of Hematology and Hematopoietic Cell Transplantation at City of Hope, sat down with Richa Thakur, a Palliative Care Physician and Hematology/Oncology Fellow at Zucker School of Medicine at Hofstra/Northwell Health, to discuss his oral abstract presentation entitled “Post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis following mismatched unrelated donor peripheral blood stem cell (PBSC) transplantation.”

This installment of Oncology Data Advisor's Exploring Artificial Intelligence (AI) in Oncology series features a discussion recorded live at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting between Ranjana Devi, Vice President of Product Development, Oncology, at Qure.ai, and Fellows Forum member Dr. Waqas Haque.

Check out the episode to hear more about:

• Qure.ai’s mission of making healthcare more accessible and equitable to patients worldwide through innovations in deep learning and AI

• Current challenges in lung cancer screening and the capabilities of AI in addressing these gaps

• Qure.ai’s end-to-end AI-powered solutions for early lung cancer detection and care

• The efficacy of these solutions and how they can be used in the clinic

• The lung cancer portfolio that Qure.ai showcased at ASCO

• Other innovations coming down the pipeline

• And more!

This playlist features interviews recorded live by Oncology Data Advisor at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting in Chicago. Visit oncdata.com to learn more!

This playlist features interviews recorded live by Oncology Data Advisor at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting in Chicago. Visit oncdata.com to learn more!